Welcome to the LogiPharma Download Centre! On this page you will find
Logistics and Supply Chain Case Studies, Reports and Interviews.
Ensure you keep up with the latest industry developmens and benchmark with pharmaceutical supply chain industry leaders. Download your content below including featured LogiPharma presentations.
Keep coming back as interviews with industry leaders, whitepapers, case studies and industry publications will be added.
|
|
|
Using Sales & Operations Planning to Future-Proof Your Supply Chain
Today’s S&OP set up will often not support and provide the new required decision making capabilities. This is a predicament faced by many pharmaceutical companies today and finding a solution to this perhaps age-old problem is potentially more profitable than being the sole manufacturer of the next blockbuster drug!
As part of developing their wider supply chain strategy, AstraZenaca are currently implementing a robust system to make sure this increasingly important area of any pharma business is being brought into the commercial fold.
LogiPharma spoke to Andy Evans, Head of Global Supply Chain Planning at AstraZeneca to tell us more…
|
|
|
|
|
SAP: Drive Product Traceability Thoughout Your Supply Network
How closely can you track prducts through your complex, widely distributed supply chains and manufacturing processes? The SAP Global Batch Traceability (SAP GBT) application provides full visibility into the genealogy of each product. An intuitive graphical interface offers the details you need to quickly track and trace any product, from raw materials through distribution.
|
|
|
|
|
Infosys Lodestone: A New Age for Successful Supplier Collaboration
With globalization, more and more industries are outsourcing key activities within their value chain to lower-cost countries. For over a decade, this has been the case for manufacturing industries such as textiles, electronics, high-tech, and consumer packaged goods - and more recently, pharmaceuticals too are joining the trend.
|
|
|
|
|
MIC Customs Solutions: Panasonic Case Study
How Panasonic Cleared Taking Care of Hardware, Legal Changes and Customs Software Release Planning:Nearly 10 years of collaboration between MIC and Panasonic Europehave led to one of the most extensive customer in-house implementations among MIC’s customer base. Each year new solutions and customer specific developments have been added and rolled out into additional countries, leading to a multi-country customs platform for Panasonic’s European businesses.
|
|
|
|
|
Espicom: Diagnostics Update
Welcome to Diagnostics Update, your update on the stories featured in Espicom's leading news service,
Diagnostics Focus.
In every issue we have a review from Laura Attwood, the Editor of Diagnostics Focus, on this month's main news
stories, plus we feature some of the major news articles covered inside the latest edition.
For more information and to start your subscription, visit www.espicom.com/df
|
|
|
|
|
The issues facing the Medical Device Industry include:
1. Reducing Cost to Serve
2. New Emerging Markets
3. Using Logistics to Differentiate and Drive Sales
By focussing on these three main challenges this White Paper reveals the best practice systems devised by DHL to provide solutions across this industry. Download to find out more
|
|
|
|
|
Evaluating the Pharma Supply Chain in Emerging Markets
According to estimates by IMS Health in October 2010, the global pharmaceutical market is expected to grow 5–7% in value to $880bn in 2011. This is a distinct improvement from industry growth of the 4-5% seen in 2010. However, the IMS predict growth of a whopping 15-17% from the Seventeen IMS defined ‘pharmerging’ countries, in 2011, rising from $170–180bn. Furthermore, the world's third-largest pharmaceutical market is China, which is predicted to grow to more than $50 billion in 2011, a remarkable 25–27%.
|
|
|
|
|
The Power of 3PL in Pharma & Healthcare
For the uninitiated, Alloga is one of the leading third party logistics providers (3PL) in the pharmaceuticals & healthcare industry.Ahead of his appearance at Logipharma, our Online Editor Dan Mellins-Cohen spent some time with the Commercial Director of Alloga Europe, Mario Johnson, to find out more about their supply chain strategy and how they are developing their European offer for supply chain/logistics through better collaboration with their pharma partners, helping them to find the balance between cost pressures and an agile, resilient supply chain.
|
|
|
|
|
Crimson & Co launch new book covering the journey to supply chain excellence
Crimson & Co, the UK’s leading end-to-end supply chain consultancy, has launched an updated version of its successful scprime® book, covering the journey to supply chain excellence.
This is version three of Crimson & Co’s established book, highlighting best practice across supply chain strategy , with a new section dedicated to people capabilities; ensuring the right people are in the right jobs doing the right things...
|
|
|
|
|
What challenges are being faced in the pharmaceutical supply chain?
The pharmaceutical industry is one that will always be in demand from people across the world but, like any other sector, it has challenges to face. In this report learn from several industry leaders from companies including Mylan, Biogen Idec, Boehringer Ingelheim, Novartis, AstraZeneca and several other about what they believe the focus should be and how they are overcoming these challenges to lead their companies to a brighter future.
|
|
|
|
|
Q&A with John Koelink, Bayer Healthcare - Pharma must be influenced by other industries to survive
Our online editor Dan-Mellins Cohen talks to John Koelink, Head of Global Supply Chain Management at Bayer Healthcare about how the pharma supply chain is developing, the key reforms that are effecting Bayer Healthcare and how they are changing the way they do business.
|
|
|
|
|
Q&A with Richard Powell, Crimson & Co
Making sure your supply chain is running at peak efficiency is at the heart of a well-oiled logistics strategy.To find out more about what you can do to get the most out of your suppliers in the pharmaceutical space, we caught up with Richard Powell, MD of leading supply chain consultants Crimson and Co. Crimson Co Logipharma interview logistics supply chain "Supply Chain" consultants segmentation emerging markets pharmaceuticals
|
|
|
|
|
CEOs: "Ignore manufacturing supply at your peril" Richard Holmes, Lodestone Management Consultants
Richard Holmes, Partner at Lodestone Management Consultants joins TheValueChain.net ahead of LogiPharma 2012 (www.logipharmaeurope.com) to discuss the latest developments in the world of the pharmaceutical supply chain.
We discussed managing complexity, integrating existing suppliers into new systems, the impact of the emerging markets, end-to-end visibility, streamlining,
|
|
|
|
|
Stephan Gotthardt, Boeringer Ingelheim
Stephan Gotthardt, Corp VP SCM, Boeringer Ingelheim joins TheValueChain.net to discuss their approach to their pharma supply chain strategy.
He explains how his function integrates across the business and the changing nature of supply chain as an business influencer.
We also uncover how they are implementing a strong, segmentation strategy, risk mitigation and coping with shocks to the supply chain, managing complexity and the differences of dealing with emerging markets.
|
|
|
|
|
The Role Of The Pharma 3PL Supplier Is Providing Consistency" - Paolo Rosanna, DHL
Interview with Paolo Rosanna, Head of Life Sciences & Healthcare Development, EMEA, DHL.
We discuss the pharma-specific side of supply chain management and how this differs from standard practice.
|
|
|
|
|
Pharma companies told to focus on supply chain issues
Europe's largest pharmaceuticals companies have been targeted as among those not paying enough attention to issues surrounding the procurement and supply chain.
A new report from the Chartered Institute of Purchasing & Supply (CIPS) has shone a startling light down on the UK FTSE 100, highlighting the fact that despite a volatile global economy and huge natural disasters seen this year, some of the country's biggest firms are not paying close enough attention to the sector.
|
|
|
|
|
Supply chain managers tighten grip on lower tier suppliers
Supply chain managers have been advised to tighten their control on second and third tier suppliers after a major new report highlighted where disruptions in the supply chain are going wrong.
Research carried out by the Business Continuity Institute (BCI) reveals that 85 per cent of global organisations have recorded at least one disruption to their supply chain so far this year, with 40 per cent of these caused from suppliers below immediate vendors.
|
|
|
|
|
WHO joins debate on counterfeit drugs in the supply chain
The World Health Organization (WHO) has weighed in on the debate of how to control pharmaceutical supply chain challenges produced from counterfeit drugs and other avenues across the world.
WHO's working group on SSFFC medicines (substandard, spurious, falsely-labelled, falsified and counterfeit) met at the end of October to draw up a draft resolution, which will be debated at the World Health Assembly in May next year.
|
|
|
|
|
Defining Key Strategies To Ensure Optimal Supply Chain Visibility, While Maintaining Product Integrity, Regulatory Compliance And Patient Safety
From our sister event LogiMed 2011, Benoit Defrasne, Business Development Manager - Supply Chain Solutions, SICPA discusses:- The role of readiness plans in assessing the gap to a full value supply chain visibility and integrity
- Aligning your supply chain to global standards for quality best practices, traceability and extended interoperability.
- Smart integration of identification, authentication and anti-tampering features.
- What can you extract from item-level traceability-based business intelligence?
- Securing the logistics of your products against diversion and theft
|
|
|
|
|
Closing Keynote Presentation: Case Study - Achieving Supply Chain Efficiency Through European Distribution Network Redesign
From our sister event LogiMed 2011, Craig Hourigan, Director, Global Supply Chain Management and Customer Service, Hollister discusses:- How to resource and structure a major network redesign project
- Top ways to achieve change management and other keys to success
- Real life lessons learned and next steps
|
|
|
|
|
Top Supply Chain Strategies To Optimise Reverse Logistics Management: Promote Efficiency And Achieve Sustainable And Responsible Care
From our sister event LogiMed 2011, Dr Philipp Schiegg, Director Corporate Supply Chain and Procurement, Siemens Healthcare discusses:
- How to keep on top of specific regulatory requirements for the disposal of your products
- Making reverse logistics green and profitable for your supply chain
- Working with customers and providers to promote responsible and sustainable care
- Developing an effective reverse logistics strategy for the return of products
|
|
|
|
|
The issues facing the Medical Device Industry include:
1. Reducing Cost to Serve
2. New Emerging Markets
3. Using Logistics to Differentiate and Drive SalesBy focussing on these three main challenges this White Paper reveals the best practice systems devised by DHL to provide solutions across this industry. Download to find out more.
|
|
|
|
|
Evaluating the Pharma Supply Chain in Emerging Markets
According to estimates by IMS Health in October 2010, the global pharmaceutical market is expected to grow 5–7% in value to $880bn in 2011. This is a distinct improvement from industry growth of the 4-5% seen in 2010. However, the IMS predict growth of a whopping 15-17% from the Seventeen IMS defined ‘pharmerging’ countries, in 2011, rising from $170–180bn. Furthermore, the world's third-largest pharmaceutical market is China, which is predicted to grow to more than $50 billion in 2011, a remarkable 25–27%.
|
|
|
|
|
U.S. Food and Drug Administration approval for DHL in The Netherlands
Nijmegen, 20 January 2011: DHL Supply Chain’s Contract Manufacturing operation at its Life Sciences & Healthcare Campus in Nijmegen, The Netherlands, has recently successfully undertaken two Good Manufacturing Practice (GMP) audits, one with the U.S. Food and Drug Administration (FDA), the second with the Brazilian FDA ANVISA.
|
|